<SEC-DOCUMENT>0001193125-12-372393.txt : 20120829
<SEC-HEADER>0001193125-12-372393.hdr.sgml : 20120829
<ACCEPTANCE-DATETIME>20120828220006
ACCESSION NUMBER:		0001193125-12-372393
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20120824
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20120829
DATE AS OF CHANGE:		20120828

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IRIDEX CORP
		CENTRAL INDEX KEY:			0001006045
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				770210467
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1230

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-27598
		FILM NUMBER:		121061275

	BUSINESS ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		6509404700

	MAIL ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d403568d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, DC 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of&nbsp;The </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act
of 1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of earliest event reported) </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>August&nbsp;24, 2012 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>IRIDEX
CORPORATION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact name of registrant as specified in its charter) </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0-27598</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>77-0210467</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1212 Terra Bella Avenue </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Mountain View, California 94043 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices,
including zip code) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(650) 940-4700 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Registrant&#146;s telephone number, including area code) </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Former name
or former address, if changed since last report) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;5.02</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
</B></FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>(b)</I></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Departure of Dominik Beck as President and Chief Executive Officer</I> </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;28, 2012, IRIDEX Corporation (the &#147;Company&#148;) announced that Dominik Beck&#146;s employment as the President and Chief Executive Officer of the Company ceased effective as of
August 24, 2012. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>(c)</I></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Appointment of William M. Moore as Interim President and Chief Executive Officer</I> </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;28, 2012, the Company announced that the Board of Directors (the &#147;Board&#148;) appointed William M. Moore, age 63, as the Company&#146;s interim President and Chief Executive Officer,
effective as of such date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee of the Board is working with Mr.&nbsp;Moore to agree upon the compensation to be
received by Mr.&nbsp;Moore in his role as interim President and Chief Executive Officer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Moore currently serves, and will continue
to serve during his tenure as interim Chief Executive Officer, as Chairman of the Board of the Company and has served as a director of the Company since September 2007. Mr.&nbsp;Moore also currently serves on the board of directors of Natus Medical
Incorporated, a public company he co-founded in 1990 and for which he served as CEO until 1993. Natus Medical Incorporated is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical
ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Mr.&nbsp;Moore served as a consultant to BlueLine Partners, a private equity firm, from February 2004 until June 2008. From
February 2008 until June 2010, Mr.&nbsp;Moore served on the board of directors of Urologix, Inc., a public company that develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. From February
2006 to February 2008, Mr.&nbsp;Moore served on the board of directors of Criticare Systems, Inc. a public company that develops, manufactures and markets patient monitoring systems and accessories used in anesthesia, critical care, medical
transport and outpatient care settings. From March 2003 until February 2004, Mr.&nbsp;Moore was a general partner of Alpine Partners, a venture capital firm. Mr.&nbsp;Moore served as CEO of Metasensors, Inc., a medical device company, from 1998 to
March 2003. Mr.&nbsp;Moore holds a B.S. in Business from the University of Utah. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are no family relationships between Mr.&nbsp;Moore and
any executive officers, directors, or other employees of the Company. Mr.&nbsp;Moore has no material interests in any transactions or proposed transactions with the Company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Appointment of James Mackaness as Chief Operating Officer </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;28, 2012, the
Company announced that the Board appointed James Mackaness, age 48, as the Company&#146;s Chief Operating Officer, effective as of such date, in addition to Mr.&nbsp;Mackaness&#146;s continuing role as the Company&#146;s Chief Financial Officer.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee of the Board is working with Mr.&nbsp;Mackaness to agree upon the compensation to be received by
Mr.&nbsp;Mackaness in his role as Chief Financial Officer and Chief Operating Officer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Mackaness joined the Company in January 2008
as Chief Financial Officer and will now serve as the Company&#146;s Chief Financial Officer and Chief Operating Officer. Prior to his appointment with the Company, from September 2001 to December 2007, Mr.&nbsp;Mackaness served as Chief Financial
Officer and Vice President of Finance of NextHop Technologies, Inc., a networking wireless technology company. Prior to that, Mr.&nbsp;Mackaness served as Vice President, Finance and Chief Financial Officer of Infogear Technologies Corporation and
held senior management positions at Cisco Systems, Inc. and Ernst&nbsp;&amp; Young LLP. Mr.&nbsp;Mackaness received his B.A. with honors in Psychology from the University of Warwick, England and is a Chartered Accountant and member of the Institute
of Chartered Accountants of England and Wales. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are no family relationships between Mr.&nbsp;Mackaness and any executive officers,
directors, or other employees of the Company. Mr.&nbsp;Mackaness has no material interests in any transactions or proposed transactions with the Company. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial Statements and Exhibits. </B></FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>(d)</I></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Exhibits </I></FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press Release dated August&nbsp;28, 2012.</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>IRIDEX CORPORATION</B></FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ JAMES H. MACKANESS</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">James H. Mackaness</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer and Chief Operating Officer</FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: August&nbsp;28, 2012 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXHIBIT INDEX </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press Release dated August&nbsp;28, 2012.</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d403568dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>FOR IMMEDIATE RELEASE</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g40356802000001c.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>IRIDEX Appoints Chairman William M. Moore as Interim President&nbsp;&amp; CEO </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>CFO James Mackaness to Assume COO Responsibilities </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Mountain View, Calif. &#150; August&nbsp;28, 2012</B> &#150; IRIDEX Corporation (Nasdaq: <U>IRIX</U>) today announced that its Board of Directors has named medical device industry veteran William M.
Moore, age 63, as interim President and Chief Executive Officer, effective immediately. Moore replaces Dominik Beck, whose employment with the Company ceased on August&nbsp;24, 2012. Moore currently serves, and will continue to serve, as Chairman of
the IRIDEX Board of Directors during his tenure as interim Chief Executive Officer. He has served as a director of the Company since September 2007. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company also announced that the Board has appointed James Mackaness, age 48, as Chief Operating Officer, effective immediately. Mr.&nbsp;Mackaness will continue to serve in his role as the
Company&#146;s Chief Financial Officer. Mackaness joined the Company in January 2008 as Chief Financial Officer. Mackaness stated, &#147;I am very glad to have this opportunity to work more closely with Mr.&nbsp;Moore and the board of directors as
the company&#146;s Chief Operating Officer. IRIDEX is a global leader in ophthalmology and I believe well positioned to deliver on its long-standing commitment to profitable operations as we continue to evolve and expand the business.&#148;
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In assuming the President and CEO role, Moore indicated that he will lead the company&#146;s strategic direction and execution in order to
increase shareholder value while Mackaness will assume more of the day-to-day operational responsibilities at IRIDEX. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Moore stated,
&#147;IRIDEX is in the unique and positive position of having both established and emerging products targeted at large and growing markets. The company has many assets, including technologies and intellectual property associated with a potential
paradigm-changing means of treating serious eye conditions, a stable balance sheet and a talented team of employees. Having been a board member for more than 5 years, I am excited about this opportunity to serve as the President and CEO of IRIDEX. I
am committed to representing the interests of all stakeholders as we work to build shareholder value.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Moore co-founded Natus Medical
Incorporated, a public company, in 1990 where he served as CEO until 1993. Natus Medical is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing
impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Mr.&nbsp;Moore still serves on the Natus Board of Directors. Moore also served as a consultant to BlueLine Partners, a private equity firm and investor
in IRIDEX, from February 2004 until June 2008. He also served on the Board of Directors of Urologix, Inc., a public medical device company. Moore holds a B.S. in Business from the University of Utah. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mackaness served as Chief Financial Officer and Vice President of Finance of NextHop Technologies, Inc., a
networking wireless technology company from September 2001 to December 2007. Prior to that, he served as Vice President, Finance and Chief Financial Officer of Infogear Technologies Corporation and held management positions at Cisco Systems, Inc.
and Ernst&nbsp;&amp; Young LLP. Mackaness received his B.A. with honors in Psychology from the University of Warwick, England and is a Chartered Accountant and member of the Institute of Chartered Accountants of England and Wales. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About IRIDEX </B> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">IRIDEX
Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology
market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX
products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit
the Company&#146;s website at http://www.iridex.com/. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Safe Harbor Statement </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This announcement contains forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended,
and Section&nbsp;21E of the Securities Act of 1934, as amended, relating to the Company&#146;s strategy and its ability to execute on that strategy and the ability to increase shareholder value. These statements are not guarantees of future
performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors. Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K
for the fiscal year ended December&nbsp;31, 2011, and our Quarterly Reports on Form 10-Q for the fiscal quarters ended March&nbsp;31, 2012 and June&nbsp;30, 2012, each of which was filed with the Securities and Exchange Commission. Forward-looking
statements contained in this announcement are made as of this date and will not be updated. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:81pt"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Company Contact:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:117pt"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Investor&nbsp;Relations&nbsp;Contact:</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jim Mackaness</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Matt Clawson</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Allen &amp; Caron</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">650-940-4700</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">949-474-4300</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">matt@allencaron.com</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g40356802000001c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g40356802000001c.jpg
M_]C_X``02D9)1@`!`0$`2`!(``#_VP!#``0#`P0#`P0$`P0%!`0%!@H'!@8&
M!@T)"@@*#PT0$`\-#PX1$Q@4$1(7$@X/%1P5%QD9&QL;$!0='QT:'Q@:&QK_
MVP!#`00%!08%!@P'!PP:$0\1&AH:&AH:&AH:&AH:&AH:&AH:&AH:&AH:&AH:
M&AH:&AH:&AH:&AH:&AH:&AH:&AH:&AK_P``1"`!;`&`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#[ZHHHH`*P
M?%/C'1O!UI#<:]?);-<2B&UA`+RW$A_ACC&6;`RS$#"J&9BJJS"3Q7XDM_">
MA7>KWD<UPEN%5+>W0O+<2NX2*)%[N\C*@]V&<#FOS2^*?Q)\2_&?QKJFGZ?J
MIAT6(&VU34;&X9XY$."UE;N,!K<'`)`_?L@FDR!!%#M1HU*]14Z:NV9U*D*4
M'.;LD>R^/?VWI6O9=.\(VUV]VA:%K#28XIKF*6.5@6>\=9;<J0%&R*"8$,6$
MXX%>6:?\>OC'9C?''INF02(BR2ZGKFHW&2N0"VZZ<*S;N0BH"<<#`QK_``N^
M#6I>(TN[#P!I4$=O9QH]S<33!%+$G8"QRSL?G(P"!C!*Y7/U9\(/AC:>$?`%
MWJ6L:5Y7BJ1;Q9YKF)?-MPI>/RXV`X0A`<@D/G<"5*@>S6P>%P4;59<T^RTM
M\SRJ6*Q&*E>E'EAW>MSY`U+X]?&B^A"`:/JD0R5>PU?4;?:^&7EENHR<9)VG
M*YP2"0,>F^"_VVKFWNX],\86ESIM\5*K%K\D:QW$F]0-E]!#&D7&<>9`R$D;
MIHP-Q]BO?AK8^.?V=_"]Q;:;'+XDM/"FGS6%Q#"OVB1H[97$`8XRK_,F"<`O
MNZ@&OF_XF_!S5_"=G90>.M.MY['4#B&2%S+&L@7.PN`-D@4DCU`8J6"L04<)
M@\:N6G+DGLDW=/\``*N)Q.%=ZD>:%M6M+'WEX6\8Z3XOLOM.D3@LH#2P.5\R
M,$L%8@$@HVQBDBDI(N&1F4ACT%?E7X!^(&N?`CQ3IB3ZC,_A9IF6PO7S(;!F
M^]%*HP7MVQEXNG'FQXE2OTQ\#^+8/&OAVUU6",6TSKLN[3S5E-M.`"T9=>''
M(*NORNC(ZDJZD^/7H5,/4=.HK-'J4JL*T%.#NF='1116!J%%%'6@#X\_;9^(
MEYH>E?V=ID8>6*..UM9%?F.^O%F0R`#^..UCG7!P0;Z*0<HIKRKX#?";3]:%
MQH5U/='[#8K=_9M)EA2\NWW;9G7SU*%5+1#!(.#P>`#'^U5;2O\`'#PY;W3%
MHK[4;W5T!((#)%!:CC`(_P"0<IP2>O;)KT'X%?"S4?'6L3:U#JMQH>GZ/,$%
MW:-BXEG9#F.-MV8]JLI9F4AA)M&<MM^BP$%2P=7$<W*]D_Z[GB8V<JF*IT%'
MF6[7]=CV_P"#?@@?#SQ'KUII=R^L:)J<<)CN7A\JXLIH]S&WNHB0P9HYDD1]
MB@C<&"YB\ST_Q+JEG9V$UG<W,45W>V\XMH6<;Y2L;,VT=3A1DUFV_@MK/3)%
MO_$>K7NH1Q%8=8F%M'=0+U`#1PHCJ#@[9%=25&X-7SSI/Q-O_$7Q*U7QA)H=
M]-X,70KG1TU\6LB0)")'D6X;`8?,Z!&`;Y00[^5C97D6J8F4JDW=K=]_^">C
M[E",806G8]U^$&JV$OPY\$Z6EY;OJ,/A?3+B2U\P>:L3VZJKE.H4E&`.,$J1
MV-<S\<?#X\:R:)HE[J-OH^BV5RM]?73@M.\KK)#;06\>")7=C*-O7(3`8G:?
M#H_%VK^&[_X8>+=&TN];0M+\&6.EWVJFPF>W1A&PF1BI4,%9H\*S*K/'C=D#
M'U(/#T'B;1H]2T?Q%JMI<:G`DL.KV_DM.('PP6-)XGCB5EV@A8PQV@DEANH:
MGAY1JP>N]^SN"<*\94Y+3;U/C7XZ?"30O"\5OH]M?:A/%J<$C"WU&2.2YVAR
M!,1%&BPH"%*!RS.2WRIY3`[G[$'Q$NH'N/!^N74\UU;7!TLJQW(72)Y;4J>I
M8PP7:,QZ1VMLO``%7OCY\*KGP+<VGB&Y\176O6^JW"V._427NQ,(Y)!F0?*R
M;8W(&%";0`#D8\8^#/B&3P;\>KO[*RHFI'2&)8#:CR:E:6LCGIU@GN5SS_K#
MV)KU\9%5\!3Q'/S23LWZZV^7ZGFX63I8R=#EY4U=+]?F?IT.1R,44@Z=<TM?
M.GN!1110!^=/[5\=W;?&30=3O%?['8ZO<Z1%(W*A9;>WND/"CAGO9E!);F)N
M0!7N'[+?@V_:2_\`%46L7-A8%_LCV,.PK>%%#`R[@<!?,X*[7R3\P4D,S]LG
MX5W?C7P_]LTY+B6X:!!;^4"P2]MO.DMU8<A4E2>[AS@$S/:+G!KR3]F[XF0>
M(K.UT3Q%XGO=%\.WLQ>^M[<K"C7*H,HUQD20QML0D*2'^Z<!WW>UA:DJF"J8
M>.]T_EU_0\K$4XPQ5.O+:S7SZ7_$^LO''Q'TJ_EU+P5X=T9_'^MW,#V]_I=J
MX%M#$XD61;JY(*0Y6.4;2=V=JX&]2?*O'(U"U#Q>+]-U'QMXHLU0Z7H.G:)<
M)H&FR>0-L@0J#>A`TF"-V2P3;&5+)[/X$\0?#ZQ^P>$?AS?:5-%!:/+!;Z2W
MVB)(XW5'9Y4RH?<P!WMO8Y/)#5V-]JUEIUWI]K=2A;F_G,-M$%+-(P5G/3H`
MJ,23@=NI`/FQDJ4M8G?*/M(NS/E?X0B[N-.TJS\.Z?K'P[\4+:1"51I,MSHN
MK`1(OFS0``1L1&/WJF,$;<2.&`'L7A[XDZ9X16S\,^.M'B^'4MO"D5BL]RC:
M;.@#82VN>$^41G]TXC=5VX7&*Z3X=:Q:WOA[2],C=1>6&D6$DD1D0N8Y(`4E
MV@DA&*2*"V,M$^,@9,GC+Q)X.L(SI'CZ^TFWM;Q-[0ZML%O(B\_,9/D."N>3
MUQ[4I2566D047!:L\6_:H\':K<:;9^)TU:ZN]*L;E$N--E*B&U+CRTGB``RV
M]MAW;V_?<,JJP/S#\#=`_P"$P^/EW(C[8]/FTF""3*D-<17L%\R8R/\`EA97
M?K@I]`>\^.WQ!T?P-IU[X?\`!GBO4]:\(;EEN;.\G^UQ1W"[/+@MKB3,DD?R
MB1OF8!AD,Q+JO2?L1_"V]L89_%/B*WVWLC&[E=Y?F>YGC4Q*T8X4Q6TC.&YR
M-19>#&PKTZ]2=+`0H2W;O\O/UU."C3C4QDJT>BM\_(^TUZ<TM%%>*>J%%%%`
M&=KVAV7B32+S2M7A\^RO(C%*F<'![@]0P."".00".0*_.GXZ?!;Q5\-O'%WX
MF\-6SZD]\6FO;2-!C55&XO<1*@`$X`+S1*HVG=+&&B,L=O\`I/6?K6BZ=X@T
MV;3];LH;^RFVEX9D#*2K!E8`]"K`,".5(!&"!5TZDZ4U.#LT1.$:D7&2NF?F
MK\+_`(O-9:I;ZUX+U+[)JD:%);:8#<\>1N1T.=R':O(/'!!!`Q[)\//C+>)\
M6;;Q+\0=2$UG<P36;/(-L.GQ2N'4QH.%4,B*SG+%!EV8KFNH^)W[%VC>+];.
MK:;,7N75FDF-V;.\,I<$.UPL4B387=_K(3,['+SMV\5_X9-^+-A:7DNF^)+^
M!;8$[=7TZ&1I54`ED$$URS=3@8W,5^Z#C/T7]IX;$P:Q-/WFK<RW/$_L^O0D
MOJ]3W4[V>QU7B;XH2#Q9X<UWP#?"";2_#=GI9O8E!%P55GD7GB2+,@`!!&Y-
MPS\K5PWQ7^,D^O7:ZQXXU"W5XX]MK:6\84!<#*HO+')Y)8GENH``%M/V5_B[
MJ.FPW%]X@OIUF;(CTK2XXI0N=N6%S):E6Y8X..`#D]*]6^'/[#NEZ<[WGC%P
M]U/$GFS33KJ%T7."[*7B6&'/S*5,=PXX*3J1DJ.987"TXK#T[R2MS/\`X`W@
M,17FW7J>ZWLO^">$_"7X3Z]\;_$UI?:W8);:;$%GL]/N07B@C)(%Y=+QN0[6
M$<.0TS+_``Q"62OTF\.:!:>&=)@TW3@QBC+R22R8,D\KL7DFD(`!=W9G9L#+
M,33/#?A?2/">GO8^'[%+*!YGGE()>2>9_OS2R,2TLC'EI'+,QY)->8_`;X.:
M_P#";^WE\1>*%\1G4[@W,D_E.CW$Y/S3R!F(#LH3/WFSNRY78D?@5:LZ\W.H
M[MGLTZ<*4%""LD>ST445D:'SQK_[:'PV\*7PL?$]MXGT6]*"06]_H4UO(4)(
MW;7P<94C/3@UO>*OVG?"'@C0M-UKQ7I7BK2=/U`LL3W6@3Q%&5B-L@8#8QP2
MH/)'(KY9_;+_`.3N/A9_UY:5_P"G*>OH']NC_DV_Q'_U]67_`*4QT`:5O^UY
MX#N=$_MV+3/%[:#M+-J:^'+AK554X9C*`5P#D'GL1UJ6\_:^^%D'AU-?T_5;
M[6=+!(NI;#39I#8G<JK]H4J#$&9PJE@`Y!"DXJC^R;KFE^'OV6O!NH:_J-II
MEA;6]TT]S=SK%%&OVR899V(`&3CD]Z^+?"EG'XD^*WQZ\1_#F%H_!=MX:\2/
M+-`C10&"6WE6)``,8=\.J$#Y8R<#;P`?<_@[]JGP7X_6X?P?I?BK5X;=)6EF
MM]`GDC5HXS(8RR@C>0`%7JQ8`=:R+/\`;/\`AOJ.N2:'86OBB[UJ.22)]/AT
M&9[A73.]3$/F!7!R,<8.:XG_`()R_P#)$-?_`.QJN/\`TDM*\W^%Z+%_P4-\
M6K$JHOG:BV%&!DPY)^I))/N:`/I"7]KCX;:9J5O8>*Y==\)3W+!8#K>@W5JK
MG."<E#@`D98X`R,GK74^/?COX1^'OAS3O$NIR7VJ>';]6>/5-'M&O;5%#(H+
MRQY10S2*JY/S'('(KJ?'7@70OB/X8OO#OBZQCO\`3+R,HZLH+1D@@2(2#M=<
MY##D&OS0^$OBK5/!_A?X^_"6_O'OM,M=#U.:W<DA8[BW?RG*+GY1(K9//6-?
M4T`?;.A?M;>"/$]FU[X:T7QIK-FLAB:>P\,W-Q&'`!*[D!&0"#CW'K6KI?[3
M?@?6?!&N>+]+36;K3-"O3::G#%ICM<VS!-Y=X1\RQ@9RYP`5;T-?.G[%7Q9\
M'_#;X!>)V\4>)=$TW48-8O+Z+3KO4HX;BX1;2#;LC)+MN9&4;58D@@`D8KZ8
M^#F@^']<TF\^)&F:4^FW?Q'L;+4-6L)+C[1`K"$@``JH.0[;C@;B<D4`4OA=
M^TWX&^,/B"31?`_]KW5U%"9I9)-.=(HE&?OOT7.,#/4TOCK]I;P;\._&B^$/
M$-IK[:Y+Y9M8K32)9Q=;P"/)('[SD[3MS\P(Z@U\7:U%=_L3_M/+J%E!=/X$
MUA6D$<:;A+8R'YXADX+PN.`2"0J$X#U]0?`#P1K/CGQ1?_'+XI60@UW68O)\
M,Z9+N?\`L?3N0I4/]V21222H'#N>/-90`>"?ME\_M;_"S_KRTK_TY3U]`_MS
MG_C&_P`1X_Y^K+_TICK\P-?\?^*?&.L66N>*/$&HZIK%F@CMKV>Y8RPK&2Z!
M6SD;79F&.A)KU#XK?%'QIXI^$7@"V\0^)]4U&WU*"\EO8YKEF6X>.[<1EQ_%
MM"C&>F!Z4`>LV/[,FE?$#]CWP_XP\':4(_'=G%<WLSPAW?48HYY5>';G[X15
M*8!)*!0/FS7HWP9^,>E_$+]D;XC>'#;V.F>(?#7A+4H;JUM(4@2>$VLGEW*Q
MJ`O)RKX_B&3C>HK)_P""<_BO6]4'BO0M1U6[NM'TNVM38V<LI:.W+R3L^Q3]
MW)Y.*^8?VB($\%_'OXA67A'=H=I]JE@\FQ<PIY4T2^;%A2/D82."GW<,1C'%
M`'VK_P`$Y>/@CKV?^AJN/_26TKSGX9@C_@H?XLR#_K-0_P#1`KYL^"7Q-\8>
M$;G5M'\,>(]2TK2VTK5[XVMM.4C-PFG3,LN/[P,49!_V!Z5PVE>/?$VC>+9_
M%&E:[?V?B&Y>66;4(IRLSO*Q,A+=<L6)/KF@#]NO$GB32?"&A7^N>)K^'3-)
ML(3+<W,S86-1^I).`%&220`"2*_+OX5>']1\:Z;^T%\4?L;66B/H>J1Q;F))
MNKIQ+Y2G;M;9&#NY!!>/@AJP/AKXGU_XW^.]!\/_`!7\0:SXIT234[4-8WFI
MS^5EI0A8*K`!MDCKN'S`,0#7OW[=C-\*/!7P^\&_#>23POX8OX=3AO-.T]S%
M'<HAM<"7'+GYFR6)+;FR3DT`6OV*?A/X/^(WP$\3#Q/X9T34=2GUF\LHM1N]
M,BGN+=#:6^W9(1O7:7+#:PP<D$'FOJ3X>:AX?^'NGZ3\+6UU;[7/#'AV">Z=
MK5X$^RIB,3,QS&F2/N[R0.>G-?D/X2^+GCKP)ILFF^#?%FKZ'I\DYG>WL[IH
MT:0A5+D#N0JC/L*Z!/B'XLO_``CXZU>[\1ZI+JFN7VFV6J71NW$EW;FVO`8I
M&!RR$1H"IX(4#IQ0!]7?$7PWXA_;5;Q5XA\,/+:>"?"-O/;>$D:,1OK-_P#(
MTKG<1A&";%)(QE.A\P#J/V"OC.VN^&;KX:^))5AU?PZI?34D!62:U+G>AR>6
MB8@8X^5E&/E)K=_X)[:G>:C\"[^"^N9)H;#Q%<6UHC'B&(V]O(47T&^1V^KD
K]37YN67C7Q%IGBI_%6G:S>VGB1Y9+IM2AF*3F:7/F.6'.6\Q\^NXT`?_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
